Initiator Pharma A/S (ST:INIT) — Stock Price
Initiator Pharma A/S (ST:INIT) is currently trading at Skr2.60 SEK, up 0.39% today. Over the past 52 weeks, shares have ranged between Skr2.24 and Skr3.95. This page tracks Initiator Pharma A/S's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Initiator Pharma A/S worth.
Initiator Pharma A/S (INIT) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Initiator Pharma A/S's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.
Initiator Pharma A/S Income Statement — Revenue, Profit & Earnings by Year
Initiator Pharma A/S's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | Skr0.00 | Skr0.00 | Skr0.00 | Skr0.00 | Skr0.00 |
| Cost of Revenue | Skr11.07K | Skr23.41K | Skr38.42K | Skr21.63K | Skr9.30K |
| Gross Profit | Skr-11.07K | Skr-23.41K | Skr-38.42 Million | Skr-21.63K | Skr-9.30K |
| Research & Development | Skr1.78K | Skr15.30K | Skr26.34K | Skr11.81K | Skr5.19K |
| SG&A | Skr3.43 Million | Skr3.62 Million | Skr3.31 Million | Skr1.44 Million | — |
| Total Operating Expenses | Skr3.43K | Skr3.62K | Skr3.31 Million | Skr1.45K | Skr1.23K |
| Operating Income | Skr-14.50K | Skr-27.03K | Skr-41.74 Million | Skr-23.07K | Skr-10.53K |
| EBITDA | Skr-14.50K | Skr-27.03K | Skr-41.74 Million | Skr-23.06K | Skr-10.51K |
| EBIT | Skr-14.50K | Skr-27.03K | Skr-41.74 Million | Skr-23.07K | Skr-10.53K |
| Interest Expense | Skr2.00K | Skr3.71 Million | Skr2.39 Million | Skr1.17 Million | Skr291.00K |
| Income Before Tax | Skr-14.84K | Skr-27.71K | Skr-44.13 Million | Skr-24.24K | Skr-10.24K |
| Income Tax Expense | Skr-1.90K | Skr-4.83K | Skr-5.68 Million | Skr-3.18K | Skr-1.54K |
| Net Income | Skr-12.93K | Skr-22.87K | Skr-38.45 Million | Skr-21.06 Million | Skr-8.70 Million |
Initiator Pharma A/S Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Initiator Pharma A/S's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | Skr15.29 Million | Skr29.79 Million | Skr48.34 Million | Skr53.70 Million | Skr15.60 Million |
| Total Current Assets | Skr15.28 Million | Skr29.77 Million | Skr48.33 Million | Skr53.70 Million | Skr15.59 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | Skr200.00K | — | — | — |
| Net Receivables | — | Skr599.00K | Skr1.71 Million | Skr945.00K | Skr545.00K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Skr510.00K | Skr18.62 Million | Skr14.32 Million | Skr18.71 Million | Skr1.19 Million |
| Total Current Liabilities | Skr510.00K | Skr3.19 Million | Skr1.75 Million | Skr5.42 Million | Skr1.19 Million |
| Long-term Debt | Skr0.00 | Skr15.44 Million | Skr12.58 Million | Skr13.29 Million | Skr0.00 |
| Net Debt | Skr-13.37 Million | Skr-8.70 Million | Skr-26.34 Million | Skr-20.86 Million | Skr-13.50 Million |
| Total Stockholder Equity | Skr14.78 Million | Skr11.16 Million | Skr34.02 Million | Skr34.99 Million | Skr14.41 Million |
| Retained Earnings | Skr8.88 Million | Skr5.65 Million | Skr28.52 Million | Skr30.40 Million | Skr11.50 Million |
Initiator Pharma A/S Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Initiator Pharma A/S generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | Skr-12.08 Million | Skr-17.65 Million | Skr-32.70 Million | Skr-34.10 Million | Skr-8.06 Million |
| Capital Expenditures | Skr0.00 | Skr0.00 | Skr0.00 | Skr0.00 | Skr0.00 |
| Free Cash Flow | Skr-12.08 Million | Skr-17.65 Million | Skr-32.70 Million | Skr-34.10 Million | Skr-8.06 Million |
| Investing Cash Flow | — | — | Skr-17.00K | Skr-17.00K | Skr-17.00K |
| Financing Cash Flow | Skr1.11 Million | Skr2.87 Million | Skr37.48 Million | Skr54.94 Million | Skr14.01 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | — | — | Skr0.00 | Skr11.00K | Skr26.00K |
| Change in Cash | Skr-10.96 Million | Skr-14.78 Million | Skr4.77 Million | Skr20.84 Million | Skr5.94 Million |
Initiator Pharma A/S Earnings History — EPS Actual vs. Analyst Estimates
Track Initiator Pharma A/S's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Feb 20, 2026 | — | — | — |
| Nov 21, 2025 | -0.09 | — | — |
| Aug 22, 2025 | -0.10 | — | — |
| May 09, 2025 | -0.07 | — | — |
| Feb 28, 2025 | -0.02 | — | — |
| Nov 29, 2024 | -0.09 | — | — |
| Aug 23, 2024 | -0.13 | — | — |
| May 10, 2024 | -0.12 | — | — |